The Scientist

» E. coli, developmental biology and immunology

Most Recent

image: Similar Data, Different Conclusions

Similar Data, Different Conclusions

By | February 23, 2016

By tweaking certain conditions of a long-running experiment on E. coli, scientists found that some bacteria could be prompted to express a mutant phenotype sooner, without the “generation of new genetic information.” The resulting debate—whether the data support evolutionary theory—is more about semantics than science.

0 Comments

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Premature Assault?

Premature Assault?

By | February 9, 2016

Plants may trick bacteria into attacking before the microbial population reaches a critical size, allowing the plants to successfully defend the weak invasion.

0 Comments

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Fungal Security Force

Fungal Security Force

By | February 1, 2016

In yew trees, Taxol-producing fungi function as an immune system to ward off pathogens.

0 Comments

image: Holding Their Ground

Holding Their Ground

By | February 1, 2016

To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

1 Comment

image: Plant Immunity

Plant Immunity

By | February 1, 2016

How plants fight off pathogens

0 Comments

image: Infection-Autism Link Explained?

Infection-Autism Link Explained?

By | January 31, 2016

A mouse study suggests a mechanism by which severe infections during pregnancy increase autism risk. 

0 Comments

image: Cross-Reactive Ebola Antibodies

Cross-Reactive Ebola Antibodies

By | January 21, 2016

Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show. 

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham